Characterization of HER1 (c-erbB1) Status in Locally Advanced Breast Cancer Using Fluorescence in situ Hybridization and Immunohistochemistry-Reference-Cited by-同舟云学术

Characterization of HER1 (c-erbB1) Status in Locally Advanced Breast Cancer Using Fluorescence in situ Hybridization and Immunohistochemistry

Published:2005 Issue:1 Volume:26 Page:25-30
ISSN:1423-0380
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol

Author:

Corzo Cristina,Tusquets Ignacio,Salido Marta,Corominas Josep Maria,Bellet Meritxell,Suarez Marta,Baró Teresa,Fabregat Xavier,Serrano Sergio,Solé Francesc

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference30 articles.

1. Baselga J: Targeting the epidermal growth factor receptor: A clinical reality.J Clin Oncol 2001;19:41-44.

2. EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival

3. The type I growth factor receptors in human breast cancer

4. Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER1R497K andHER2I655V Polymorphisms Are Linked to Development of Breast Cancer;Disease Markers;2013

2. EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia;Journal of Receptors and Signal Transduction;2012-03-06

3. Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast;Histopathology;2011-08

4. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast;Modern Pathology;2010-03-05

5. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: Agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells;Cellular Signalling;2009-03